About
Keith Murphy is a U.S. biotech executive and company builder best known for founding Organovo in 2007 and later co-founding Viscient Bio in 2017. As of March 2025, he serves as Director and Executive Chairman of Organovo and CEO and Chairman of Viscient Bio, and he joined the Matinas BioPharma board as an independent director. He is also active in sector advocacy and governance through No Patient Left Behind and California Life Sciences.
Areas of interest
biotechdrug discovery3D bioprintingregenerative medicinelife sciences policyrare disease advocacybiopharma M&A